Vasoactive peptides associate with treatment outcome ofbevacizumab-containing therapy in metastatic colorectal cancer
(2017) In Acta Oncologica 56(5). p.653-660
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4765b0c5-55e3-4742-b539-e499e76ec61f
- author
- Hagman, Helga LU ; Bendahl, Pär-Ola LU ; Melander, Olle LU ; Sundberg, Jan ; Johnsson, Anders LU and Belting, Mattias LU
- organization
- publishing date
- 2017-04
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Acta Oncologica
- volume
- 56
- issue
- 5
- pages
- 653 - 660
- publisher
- Taylor & Francis
- external identifiers
-
- pmid:28303751
- scopus:85015663945
- wos:000400270300005
- ISSN
- 1651-226X
- DOI
- 10.1080/0284186X.2017.1302098
- language
- English
- LU publication?
- yes
- id
- 4765b0c5-55e3-4742-b539-e499e76ec61f
- date added to LUP
- 2017-04-12 16:39:05
- date last changed
- 2024-01-13 18:47:04
@article{4765b0c5-55e3-4742-b539-e499e76ec61f, author = {{Hagman, Helga and Bendahl, Pär-Ola and Melander, Olle and Sundberg, Jan and Johnsson, Anders and Belting, Mattias}}, issn = {{1651-226X}}, language = {{eng}}, number = {{5}}, pages = {{653--660}}, publisher = {{Taylor & Francis}}, series = {{Acta Oncologica}}, title = {{Vasoactive peptides associate with treatment outcome ofbevacizumab-containing therapy in metastatic colorectal cancer}}, url = {{http://dx.doi.org/10.1080/0284186X.2017.1302098}}, doi = {{10.1080/0284186X.2017.1302098}}, volume = {{56}}, year = {{2017}}, }